Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bellicum Pharmaceuticals Inc (NASDAQ:BLCM)

10.31
Delayed Data
As of Oct 19
 -0.10 / -0.96%
Today’s Change
7.41
Today|||52-Week Range
23.11
-24.30%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Baker Bros Advisors Lp
Buy3/24/2017151,177$12.00$1.8M-14.37%
Slawin Kevin M
Chief Technology Officer
Sale12/15/201630,000$15.45$463.5K-34.04%
Musso Alan A
Chief Financial Officer & Treasurer
Sale11/28/201622,427$19.23$431.3K-45.31%
Slawin Kevin M
Director
Sale2/07/201730,000$12.54$376.2K-17.98%
Moseley Annemarie B
Sale12/01/201614,458$17.17$248.2K-39.28%
Moseley Annemarie B
Sale12/01/201610,542$18.04$190.2K-39.28%
Baker Bros Advisors Lp
Buy3/24/201715,489$12.00$185.9K-14.37%
Moseley Kenneth Ray
General Counsel & Senior Vice President
Sale7/13/201713,823$12.26$169.5K-15.91%
Musso Alan A
Chief Financial Officer & Treasurer
Sale11/25/20166,273$20.48$128.5K-50.07%
Spencer David M
Chief Scientific Officer
Sale7/10/201710,000$11.54$115.4K-9.48%
Page of 2